CN Stock MarketDetailed Quotes

300841 Chengdu Kanghua Biological Products

Watchlist
  • 51.78
  • -0.82-1.56%
Market Closed Jan 3 15:00 CST
6.88BMarket Cap12.60P/E (TTM)

Chengdu Kanghua Biological Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
1.58%762.34M
19.06%770.07M
58.78%1.01B
59.54%1.04B
28.82%750.49M
1.76%646.79M
-6.43%634.73M
-29.71%651.46M
-28.21%582.59M
-30.27%635.63M
Transactional financial assets
----
----
--50M
----
----
----
----
----
----
----
Notes receivable and accounts receivable
5.78%1.39B
7.96%1.43B
4.24%1.36B
9.59%1.41B
8.75%1.32B
20.71%1.32B
38.18%1.31B
53.74%1.29B
95.71%1.21B
77.99%1.1B
-Notes receivable
--700K
----
----
----
----
----
----
----
----
----
-Accounts receivable
5.72%1.39B
7.96%1.43B
4.24%1.36B
9.59%1.41B
8.75%1.32B
20.71%1.32B
38.18%1.31B
53.74%1.29B
95.71%1.21B
77.99%1.1B
Other receivables (including interest and dividends)
-24.20%13.29M
-23.45%13.26M
-8.53%16.95M
-7.57%16.38M
-10.79%17.53M
-10.76%17.32M
484.36%18.53M
587.09%17.72M
614.35%19.65M
631.99%19.41M
-Other receivable
----
-23.45%13.26M
----
----
----
-10.76%17.32M
----
587.09%17.72M
----
631.99%19.41M
Advance payment
-52.94%10.57M
-54.96%13.32M
-38.99%18.91M
-51.43%17.09M
-58.00%22.46M
-59.93%29.58M
-71.79%31M
-49.96%35.19M
-30.00%53.47M
63.06%73.82M
Inventories
-2.02%180.44M
1.34%193.76M
2.02%189.11M
12.95%173.54M
19.78%184.16M
15.55%191.19M
28.77%185.37M
45.65%153.65M
95.94%153.75M
175.70%165.46M
Other current assets
----
----
----
----
----
----
----
----
--103.22K
--204.28K
Total current assets
2.97%2.36B
9.55%2.42B
21.54%2.64B
23.86%2.66B
13.42%2.29B
10.92%2.21B
9.83%2.18B
10.42%2.15B
18.32%2.02B
11.53%1.99B
Non Current assets
Other non-current financial assets
-11.19%461.75M
-11.08%466.29M
-8.56%471.39M
-6.29%470.87M
12.47%519.91M
16.51%524.41M
7.15%515.52M
7.23%502.47M
5.66%462.27M
140.84%450.11M
Long-term equity investment
--6.5M
--6.5M
--6.5M
--6.5M
----
----
----
----
----
----
Fixed assets
----
64.62%825.97M
----
----
----
73.88%501.73M
----
85.76%461.66M
----
248.44%288.55M
Constru in process
----
-74.48%119.38M
----
----
----
73.04%467.87M
----
119.24%523.35M
----
75.10%270.38M
Intangible assets
-1.21%15.83M
-2.88%15.78M
-11.18%15.37M
-10.78%15.38M
-7.99%16.02M
-12.46%16.24M
-7.49%17.31M
-8.17%17.23M
-10.18%17.41M
-6.83%18.56M
Long deferred expense
9.65%137.02M
57.14%117.42M
96.52%107.01M
75.58%94.39M
137.21%124.97M
95.60%74.72M
46.07%54.45M
49.05%53.76M
50.86%52.68M
6.86%38.2M
Deferred tax assets
--525.07K
--1.25M
----
----
----
----
----
----
615.22%10.66M
1,693.57%19.79M
Usufruct assets
----
----
----
----
----
-80.00%149.37K
-73.13%298.74K
-69.82%448.11K
-67.83%597.48K
-66.52%746.85K
Other non current assets
-48.87%3.99M
-40.01%6.56M
-2.03%7.45M
-44.08%3.94M
-95.04%7.81M
-91.85%10.94M
-89.28%7.6M
-87.47%7.05M
18.35%157.52M
123.61%134.26M
Total non current assets
-2.00%1.59B
-2.31%1.56B
-1.10%1.56B
-0.87%1.55B
20.37%1.62B
30.76%1.6B
40.42%1.57B
45.61%1.57B
45.41%1.35B
124.72%1.22B
Total assets
0.91%3.95B
4.58%3.98B
12.03%4.2B
13.42%4.21B
16.20%3.92B
18.46%3.81B
20.89%3.75B
22.96%3.71B
27.85%3.37B
37.93%3.21B
Liabilities
Current liabilities
Short term loan
71.95%216.43M
27.03%176.4M
71.80%210.19M
74.68%190.91M
-6.33%125.87M
4.97%138.86M
205.86%122.35M
--109.3M
--134.38M
--132.28M
Notes payable and accounts payable
-82.81%6.15M
-87.54%6.22M
-70.26%11.27M
-79.12%7.13M
19.17%35.78M
128.00%49.89M
91.17%37.9M
463.57%34.14M
411.46%30.03M
78.09%21.88M
-Notes payable
-96.19%937.62K
----
----
-77.53%4M
61.80%24.6M
521.71%37.7M
--22.06M
--17.8M
--15.2M
--6.06M
-Accounts payable
-53.37%5.21M
-49.00%6.22M
-28.82%11.27M
-80.85%3.13M
-24.56%11.18M
-22.92%12.19M
-20.14%15.83M
169.68%16.34M
152.47%14.82M
28.74%15.82M
Contract liabilities
-68.49%105.61K
-41.76%207.37K
118.31%184.51K
26.29%295.51K
1.79%335.17K
664.04%356.06K
-75.34%84.52K
--234K
--329.27K
--46.6K
Salaries payable
-20.13%20.62M
21.23%17.4M
37.39%14.37M
23.47%34.94M
45.24%25.81M
-18.21%14.35M
-10.83%10.46M
13.61%28.3M
57.32%17.77M
54.37%17.54M
Taxs payable
-28.05%11.78M
16.47%22.47M
6.43%17.14M
81.75%42.22M
-28.34%16.37M
-53.53%19.3M
8.03%16.11M
-33.90%23.23M
-17.96%22.84M
13.65%41.52M
Other payable (including interest and dividends)
-24.81%230.95M
2.12%306.56M
-6.03%335.36M
-2.16%406.22M
63.95%307.16M
63.30%300.19M
78.42%356.87M
52.51%415.19M
70.50%187.35M
49.73%183.83M
-Other payable
----
2.12%306.56M
----
----
----
63.30%300.19M
----
52.51%415.19M
----
49.73%183.83M
Non current liabilities due within one year
----
----
----
----
118.74%1M
64.36%1M
92.38%1.15M
120.15%1.31M
-55.57%457.17K
-58.53%608.4K
Other current liabilities
-68.49%3.17K
17.79%6.22K
114.34%5.54K
26.29%8.87K
1.79%10.06K
277.79%5.28K
--2.58K
--7.02K
--9.88K
--1.4K
Total current liabilities
-5.13%486.03M
1.01%529.26M
8.00%588.53M
11.45%681.72M
30.31%512.33M
31.74%523.96M
89.59%544.93M
80.48%611.71M
152.16%393.16M
115.65%397.71M
Current liabilities
Long term loan
----
----
----
----
--15.25M
--15.25M
--15.75M
--15.75M
----
----
Estimate liabilities
5.50%3.81M
0.18%3.22M
18.34%4.02M
20.33%4.79M
-34.17%3.61M
-48.45%3.22M
-14.34%3.4M
5.71%3.98M
98.90%5.48M
122.65%6.24M
Deferred tax liabilities
----
----
-61.01%1.9M
-36.86%2.5M
-24.34%4.91M
-19.51%4.96M
-26.36%4.87M
-16.30%3.96M
--6.48M
--6.16M
Long term deferred income
7,198.92%6.17M
--6.18M
--6.2M
--6.2M
--84.49K
----
----
----
----
----
Total non current liabilities
-58.17%9.98M
-59.85%9.4M
-49.54%12.12M
-43.05%13.49M
99.25%23.85M
88.91%23.42M
123.71%24.02M
169.08%23.69M
272.41%11.97M
263.86%12.4M
Total liabilities
-7.49%496.01M
-1.59%538.67M
5.57%600.65M
9.41%695.22M
32.35%536.18M
33.47%547.38M
90.81%568.94M
82.72%635.4M
154.59%405.13M
118.34%410.11M
Shareholders equity
Paid-in capital
0.00%134.65M
0.00%134.65M
0.00%134.65M
0.00%134.65M
0.00%134.65M
0.00%134.65M
49.61%134.65M
49.61%134.65M
49.61%134.65M
49.61%134.65M
Capital reserve funds
-0.44%1.18B
-0.44%1.18B
-0.39%1.18B
-0.33%1.18B
-0.18%1.18B
-0.07%1.18B
-3.23%1.18B
-2.98%1.18B
-2.40%1.19B
-2.21%1.19B
Surplus reserve funds
0.00%67.33M
0.00%67.33M
0.00%67.33M
0.00%67.33M
49.61%67.33M
49.61%67.33M
49.61%67.33M
49.61%67.33M
50.00%45M
50.00%45M
Retained profit
13.28%2.4B
15.16%2.3B
25.36%2.41B
24.39%2.26B
22.92%2.12B
28.42%1.99B
27.34%1.92B
32.23%1.81B
50.93%1.72B
91.99%1.55B
Less:Treasury stock
162.47%323.1M
92.91%237.47M
50.72%185.53M
0.00%123.1M
0.00%123.1M
6.14%123.1M
101.83%123.1M
120.27%123.1M
--123.1M
--115.98M
Shareholders equity without minority interests
2.24%3.45B
5.61%3.44B
13.19%3.6B
14.25%3.51B
13.99%3.38B
16.27%3.26B
13.45%3.18B
15.18%3.08B
19.71%2.96B
30.87%2.8B
Total shareholder equity
2.24%3.45B
5.61%3.44B
13.19%3.6B
14.25%3.51B
13.99%3.38B
16.27%3.26B
13.45%3.18B
15.18%3.08B
19.71%2.96B
30.87%2.8B
Total liabilityies and equity
0.91%3.95B
4.58%3.98B
12.03%4.2B
13.42%4.21B
16.20%3.92B
18.46%3.81B
20.89%3.75B
22.96%3.71B
27.85%3.37B
37.93%3.21B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 1.58%762.34M19.06%770.07M58.78%1.01B59.54%1.04B28.82%750.49M1.76%646.79M-6.43%634.73M-29.71%651.46M-28.21%582.59M-30.27%635.63M
Transactional financial assets ----------50M----------------------------
Notes receivable and accounts receivable 5.78%1.39B7.96%1.43B4.24%1.36B9.59%1.41B8.75%1.32B20.71%1.32B38.18%1.31B53.74%1.29B95.71%1.21B77.99%1.1B
-Notes receivable --700K------------------------------------
-Accounts receivable 5.72%1.39B7.96%1.43B4.24%1.36B9.59%1.41B8.75%1.32B20.71%1.32B38.18%1.31B53.74%1.29B95.71%1.21B77.99%1.1B
Other receivables (including interest and dividends) -24.20%13.29M-23.45%13.26M-8.53%16.95M-7.57%16.38M-10.79%17.53M-10.76%17.32M484.36%18.53M587.09%17.72M614.35%19.65M631.99%19.41M
-Other receivable -----23.45%13.26M-------------10.76%17.32M----587.09%17.72M----631.99%19.41M
Advance payment -52.94%10.57M-54.96%13.32M-38.99%18.91M-51.43%17.09M-58.00%22.46M-59.93%29.58M-71.79%31M-49.96%35.19M-30.00%53.47M63.06%73.82M
Inventories -2.02%180.44M1.34%193.76M2.02%189.11M12.95%173.54M19.78%184.16M15.55%191.19M28.77%185.37M45.65%153.65M95.94%153.75M175.70%165.46M
Other current assets ----------------------------------103.22K--204.28K
Total current assets 2.97%2.36B9.55%2.42B21.54%2.64B23.86%2.66B13.42%2.29B10.92%2.21B9.83%2.18B10.42%2.15B18.32%2.02B11.53%1.99B
Non Current assets
Other non-current financial assets -11.19%461.75M-11.08%466.29M-8.56%471.39M-6.29%470.87M12.47%519.91M16.51%524.41M7.15%515.52M7.23%502.47M5.66%462.27M140.84%450.11M
Long-term equity investment --6.5M--6.5M--6.5M--6.5M------------------------
Fixed assets ----64.62%825.97M------------73.88%501.73M----85.76%461.66M----248.44%288.55M
Constru in process -----74.48%119.38M------------73.04%467.87M----119.24%523.35M----75.10%270.38M
Intangible assets -1.21%15.83M-2.88%15.78M-11.18%15.37M-10.78%15.38M-7.99%16.02M-12.46%16.24M-7.49%17.31M-8.17%17.23M-10.18%17.41M-6.83%18.56M
Long deferred expense 9.65%137.02M57.14%117.42M96.52%107.01M75.58%94.39M137.21%124.97M95.60%74.72M46.07%54.45M49.05%53.76M50.86%52.68M6.86%38.2M
Deferred tax assets --525.07K--1.25M------------------------615.22%10.66M1,693.57%19.79M
Usufruct assets ---------------------80.00%149.37K-73.13%298.74K-69.82%448.11K-67.83%597.48K-66.52%746.85K
Other non current assets -48.87%3.99M-40.01%6.56M-2.03%7.45M-44.08%3.94M-95.04%7.81M-91.85%10.94M-89.28%7.6M-87.47%7.05M18.35%157.52M123.61%134.26M
Total non current assets -2.00%1.59B-2.31%1.56B-1.10%1.56B-0.87%1.55B20.37%1.62B30.76%1.6B40.42%1.57B45.61%1.57B45.41%1.35B124.72%1.22B
Total assets 0.91%3.95B4.58%3.98B12.03%4.2B13.42%4.21B16.20%3.92B18.46%3.81B20.89%3.75B22.96%3.71B27.85%3.37B37.93%3.21B
Liabilities
Current liabilities
Short term loan 71.95%216.43M27.03%176.4M71.80%210.19M74.68%190.91M-6.33%125.87M4.97%138.86M205.86%122.35M--109.3M--134.38M--132.28M
Notes payable and accounts payable -82.81%6.15M-87.54%6.22M-70.26%11.27M-79.12%7.13M19.17%35.78M128.00%49.89M91.17%37.9M463.57%34.14M411.46%30.03M78.09%21.88M
-Notes payable -96.19%937.62K---------77.53%4M61.80%24.6M521.71%37.7M--22.06M--17.8M--15.2M--6.06M
-Accounts payable -53.37%5.21M-49.00%6.22M-28.82%11.27M-80.85%3.13M-24.56%11.18M-22.92%12.19M-20.14%15.83M169.68%16.34M152.47%14.82M28.74%15.82M
Contract liabilities -68.49%105.61K-41.76%207.37K118.31%184.51K26.29%295.51K1.79%335.17K664.04%356.06K-75.34%84.52K--234K--329.27K--46.6K
Salaries payable -20.13%20.62M21.23%17.4M37.39%14.37M23.47%34.94M45.24%25.81M-18.21%14.35M-10.83%10.46M13.61%28.3M57.32%17.77M54.37%17.54M
Taxs payable -28.05%11.78M16.47%22.47M6.43%17.14M81.75%42.22M-28.34%16.37M-53.53%19.3M8.03%16.11M-33.90%23.23M-17.96%22.84M13.65%41.52M
Other payable (including interest and dividends) -24.81%230.95M2.12%306.56M-6.03%335.36M-2.16%406.22M63.95%307.16M63.30%300.19M78.42%356.87M52.51%415.19M70.50%187.35M49.73%183.83M
-Other payable ----2.12%306.56M------------63.30%300.19M----52.51%415.19M----49.73%183.83M
Non current liabilities due within one year ----------------118.74%1M64.36%1M92.38%1.15M120.15%1.31M-55.57%457.17K-58.53%608.4K
Other current liabilities -68.49%3.17K17.79%6.22K114.34%5.54K26.29%8.87K1.79%10.06K277.79%5.28K--2.58K--7.02K--9.88K--1.4K
Total current liabilities -5.13%486.03M1.01%529.26M8.00%588.53M11.45%681.72M30.31%512.33M31.74%523.96M89.59%544.93M80.48%611.71M152.16%393.16M115.65%397.71M
Current liabilities
Long term loan ------------------15.25M--15.25M--15.75M--15.75M--------
Estimate liabilities 5.50%3.81M0.18%3.22M18.34%4.02M20.33%4.79M-34.17%3.61M-48.45%3.22M-14.34%3.4M5.71%3.98M98.90%5.48M122.65%6.24M
Deferred tax liabilities ---------61.01%1.9M-36.86%2.5M-24.34%4.91M-19.51%4.96M-26.36%4.87M-16.30%3.96M--6.48M--6.16M
Long term deferred income 7,198.92%6.17M--6.18M--6.2M--6.2M--84.49K--------------------
Total non current liabilities -58.17%9.98M-59.85%9.4M-49.54%12.12M-43.05%13.49M99.25%23.85M88.91%23.42M123.71%24.02M169.08%23.69M272.41%11.97M263.86%12.4M
Total liabilities -7.49%496.01M-1.59%538.67M5.57%600.65M9.41%695.22M32.35%536.18M33.47%547.38M90.81%568.94M82.72%635.4M154.59%405.13M118.34%410.11M
Shareholders equity
Paid-in capital 0.00%134.65M0.00%134.65M0.00%134.65M0.00%134.65M0.00%134.65M0.00%134.65M49.61%134.65M49.61%134.65M49.61%134.65M49.61%134.65M
Capital reserve funds -0.44%1.18B-0.44%1.18B-0.39%1.18B-0.33%1.18B-0.18%1.18B-0.07%1.18B-3.23%1.18B-2.98%1.18B-2.40%1.19B-2.21%1.19B
Surplus reserve funds 0.00%67.33M0.00%67.33M0.00%67.33M0.00%67.33M49.61%67.33M49.61%67.33M49.61%67.33M49.61%67.33M50.00%45M50.00%45M
Retained profit 13.28%2.4B15.16%2.3B25.36%2.41B24.39%2.26B22.92%2.12B28.42%1.99B27.34%1.92B32.23%1.81B50.93%1.72B91.99%1.55B
Less:Treasury stock 162.47%323.1M92.91%237.47M50.72%185.53M0.00%123.1M0.00%123.1M6.14%123.1M101.83%123.1M120.27%123.1M--123.1M--115.98M
Shareholders equity without minority interests 2.24%3.45B5.61%3.44B13.19%3.6B14.25%3.51B13.99%3.38B16.27%3.26B13.45%3.18B15.18%3.08B19.71%2.96B30.87%2.8B
Total shareholder equity 2.24%3.45B5.61%3.44B13.19%3.6B14.25%3.51B13.99%3.38B16.27%3.26B13.45%3.18B15.18%3.08B19.71%2.96B30.87%2.8B
Total liabilityies and equity 0.91%3.95B4.58%3.98B12.03%4.2B13.42%4.21B16.20%3.92B18.46%3.81B20.89%3.75B22.96%3.71B27.85%3.37B37.93%3.21B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Virus Prevention
Virus Prevention
Intraday-0.69%
Biological Vaccine
Biological Vaccine
Intraday-0.85%
Transferring Securities of Securities
Transferring Securities of Securities
Intraday-1.58%